Real-Time Clinical Trials: A Concept Change?
The FDA announcement on Real-Time Clinical Trials looks important because it is not only about one new digital feature or one more modernization initiative. It questions the traditional rhythm of clinical development. Real-Time Clinical Trials describe a model in which clinical, operational, quality, and safety data are continuously integrated and analysed throughout the study, enabling proactive oversight and timely decision-making instead of relying primarily on periodic monitoring and retrospective review. https://www.fda.gov/news-events/press-announcements/fda-announces-major-steps-implement-real-time-clinical-trials For many years, the clinical trial process has followed a familiar sequence. A study is designed. Sites collect data. Data are entered, cleaned, queried, reviewed, analyzed, summarized, and finally submitted to the regulator. The regulator then reviews the evidence after a significant part of the operational and analytical work has already happened. This model is...